US$ 26.02
bpc 157 transdermal Body Protective Compound bpc 157 transdermal gel 4
Description
Metabolic Pharmaceuticals terminated drug development in March 2007

NaBPC157 appears to be well suited for use in the treatment of Parkinson's disease and Parkinson's disease-like pathologies

LiveWell ships fast with free domestic shipping plus international shipping to Colombia, Mexico, Brazil, Argentina, Chile, and Peru

They are not approved by the U.S

It is for licensed researchers and laboratory staff running preclinical studies on tissue repair, inflammation pathways, and gut barrier biology under sterile conditions
